Public-private Collaborations and Partnerships in Stratified Medicine

Making Sense of New Interactions

Joanna Chataway, Caroline Viola Fry, Sonja Marjanovic, Ohid Yaqub

ResearchPosted on rand.org Sep 1, 2012Published in: New Biotechnology, v. 29, no. 6, Sep. 2012, p. 732-740

The field of personalised or stratified medicine is evolving alongside the formation of a plethora of public-private partnerships. Such collaborations are at the core of the set of new life sciences policies in the UK, but the rationale and basis for collaboration remains unclear and there is little indication in policy documents of clear boundaries for them. An article in the journal New Biotechnology discusses some of the drivers and dynamics of these collaborations.

Read More

Topics

Document Details

Research conducted by

This publication is part of the RAND external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

RAND is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.